Clinical Trials Browser

Phase NA × INDUSTRY × Capecitabine × Clear all

NCT04894643 2025-05-08

PARC

Phase NA Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT01369433 2020-09-01

A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols

Phase NA Terminated

225 enrolled 7 charts

Other solid neoplasm

Solid Tumors